Abstract 3895: A phase I-II pharmacokinetic drug-drug interaction evaluation of oral palbociclib in combination with vemurafenib in patients suffering metastatic melanoma with BRAF V600 mutated and CDKN2A loss & expression of Rb
Huguet, Samuel, Lesimple, Thierry, Geraud, Arthur, Amini-Adle, Mouna, Dutriaux, Caroline, Meda, Laetitia Da, Capelle, Florence, Ghrieb, Zineb, Mourah, Samia, Madar, Olivier, Bouton, Didier, Resche-Rigon, Mathieu, Lebbe, Celest, Rezai, Keyvan
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article